GlassScriptPhysician profile
Chelsea E Christensen
NPI 1164898508
$21,121.46
in general payments reported to CMS, 2019-2025
13 companies · $15K in 2025
The $15K reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $950 · 2022: $890 · 2023: $569 · 2024: $3,514 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Travel and Lodging: $2,642 · Food and Beverage: $2,339 · Consulting Fee: $800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,500.00 |
| Travel and Lodging | $2,641.96 |
| Food and Beverage | $2,339.44 |
| Consulting Fee | $800.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17,073.29 | 2021-2025 | Lifevest |
| Abbott Laboratories | $2,242.70 | 2021-2025 | Cardiomems |
| Novartis Pharmaceuticals Corporation | $451.78 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $248.99 | 2021-2023 | Xarelto |
| Boston Scientific Corporation | $223.48 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $221.81 | 2022-2023 | Farxiga |
| Kiniksa Pharmaceuticals, LTD. | $124.93 | 2021 | |
| Amgen INC. | $124.75 | 2024 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.62 | 2022 | |
| Lilly USA, LLC | $112.78 | 2022 | |
| Medtronic, INC. | $104.93 | 2021-2022 | |
| Amarin Pharma, INC. | $51.85 | 2023 | |
| Scpharmaceuticals INC. | $15.55 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chelsea Christensen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.